Search Results - "Šťastná, Dominika"
-
1
Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences
Published in Multiple sclerosis (01-10-2023)“…Background: Early diagnosis and treatment of patients with multiple sclerosis (MS) are associated with better outcomes; however, diagnostic delays remain a…”
Get full text
Journal Article -
2
Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab
Published in Frontiers in immunology (16-06-2023)“…Rituximab (RTX) and ocrelizumab (OCR), B cell-depleting therapy targeting CD20 molecules, affect the humoral immune response after vaccination. How these…”
Get full text
Journal Article -
3
The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021
Published in Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia (01-09-2024)“…Multiple sclerosis treatment strategies are changing in the Czech Republic. According to data from 2013-2021, the proportion of patients starting high-efficacy…”
Get full text
Journal Article -
4
Brainstem lesions are associated with diffuse spinal cord involvement in early multiple sclerosis
Published in BMC neurology (19-07-2022)“…Background Early infratentorial and focal spinal cord lesions on magnetic resonance imaging (MRI) are associated with a higher risk of long-term disability in…”
Get full text
Journal Article -
5
Real-world effectiveness of cladribine as an escalation strategy for MS: Insights from the Czech nationwide ReMuS registry
Published in Journal of central nervous system disease (01-06-2024)“…Cladribine, a selective immune reconstitution therapy, is approved for the treatment of adult patients with highly active multiple sclerosis (MS). Provide…”
Get full text
Journal Article -
6
Internal comorbidities and complications of multiple sclerosis therapy - don't be caught off guard
Published in Vnitřní lékar̆stvĭ (01-10-2023)“…Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system, mainly affecting young adults. Factors positively influencing its course…”
Get more information
Journal Article -
7
COVID‐19 vaccination and relapse activity: A nationwide cohort study of patients with multiple sclerosis in Denmark
Published in European journal of neurology (01-03-2024)“…Background and purpose We evaluated whether there was a difference in the occurrence of relapses pre‐ and post‐COVID‐19 vaccination in a nationwide cohort of…”
Get full text
Journal Article -
8
Effectiveness of Tixagevimab/Cilgavimab (Evusheld) in AntiCD20 Treated Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder (P8-6.006)
Published in Neurology (09-04-2024)“…Abstract only…”
Get full text
Journal Article -
9
Missed diagnosis of Fabry disease: should we screen patients with multiple sclerosis?
Published in Neurological sciences (01-01-2024)“…Introduction Fabry disease (FD) can be undiagnosed in the context of multiple sclerosis (MS) due to similar clinical and paraclinical features. Our study aimed…”
Get full text
Journal Article -
10
Effect of Tai-chi on balance, mood, cognition, and quality of life in women with multiple sclerosis: A one-year prospective study
Published in Explore (New York, N.Y.) (01-03-2024)“…•One year of regular Tai-chi training improved several symptoms of multiple sclerosis.•Significant improvements were found in all objective balance and gait…”
Get full text
Journal Article -
11
Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia
Published in Multiple sclerosis and related disorders (01-09-2021)“…•Majority of MS patients had a mild COVID-19 course.•The COVID-19 incidence in MS patients seems to be similar to the general population.•Higher age and BMI…”
Get full text
Journal Article -
12
To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection
Published in Multiple sclerosis and related disorders (01-09-2022)“…•There is an increase in the MS relapse incidence after COVID-19 infection.•There is a mild increase in the MS relapse incidence after COVID-19…”
Get full text
Journal Article -
13
COVID-19 and multiple sclerosis: challenges and lessons for patient care
Published in The Lancet regional health. Europe (01-09-2024)“…During the COVID-19 pandemic, people with multiple sclerosis (MS) and their healthcare providers have faced unique challenges related to the interaction…”
Get full text
Journal Article -
14